Equitas Small Finance Bank Limited carries a market capitalization of 89.40B, placing it among publicly traded companies globally. Its enterprise value stands at 76.57B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 89.40B |
| Enterprise Value | 76.57B |
Equitas Small Finance Bank Limited trades at a trailing price-to-earnings ratio of 56.90.
| PE Ratio | 56.90 |
| PS Ratio | 2.40 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
| EV / Sales | 2.40 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Debt / Equity | 53.44 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Over the trailing twelve months, Equitas Small Finance Bank Limited has paid -390.98M in income taxes, reflecting an effective tax rate of 47.10.
| Income Tax | -390.98M |
| Effective Tax Rate | 47.10 |
Equitas Small Finance Bank Limited's stock has gained approximately 25.37289% over the past 52 weeks. The 50-day moving average sits at 72.62, while the 200-day moving average is 64.62.
| Beta (5Y) | N/A |
| 52-Week Price Change | 25.37289% |
| 50-Day Moving Average | 72.62 |
| 200-Day Moving Average | 64.62 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Equitas Small Finance Bank Limited generated 31.89B in revenue and converted that into -1.15B in net income, yielding earnings per share of -1.01.
| Revenue | 31.89B |
| Gross Profit | N/A |
| Operating Income | N/A |
| Pretax Income | -1.54B |
| Net Income | -1.15B |
| EBITDA | N/A |
| EBIT | N/A |
| Earnings Per Share (EPS) | -1.01 |
Equitas Small Finance Bank Limited operates with a gross margin of 100.00, reflecting its pricing power and cost economics.
| Gross Margin | 100.00 |
| Operating Margin | N/A |
| Pretax Margin | -4.84 |
| Profit Margin | -3.62 |
| EBITDA Margin | N/A |
Equitas Small Finance Bank Limited posts an Altman Z-Score of 0.22, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.22 |